Molecular Oncology (Mar 2019)

Cancer Prevention Europe

  • Christopher P. Wild,
  • Carolina Espina,
  • Linda Bauld,
  • Bernardo Bonanni,
  • Hermann Brenner,
  • Karen Brown,
  • Joakim Dillner,
  • David Forman,
  • Ellen Kampman,
  • Mef Nilbert,
  • Karen Steindorf,
  • Hans Storm,
  • Paolo Vineis,
  • Michael Baumann,
  • Joachim Schüz

DOI
https://doi.org/10.1002/1878-0261.12455
Journal volume & issue
Vol. 13, no. 3
pp. 528 – 534

Abstract

Read online

The case for cancer prevention in Europe is the same as for all other parts of the world. The number of cancers is increasing, driven by demographic change and evolution in the exposure to risk factors, while the cost of treating patients is likewise spiralling. Estimations suggest that around 40% of cancers in Europe could be prevented if current understanding of risk and protective factors was translated into effective primary prevention, with further reductions in cancer incidence and mortality by screening, other approaches to early detection, and potentially medical prevention. However, the infrastructure for cancer prevention tends to be fragmented between and within different countries in Europe. This lack of a coordinated approach recently led to the foundation of Cancer Prevention Europe (Forman et al., 2018), a collaborative network with the main aims of strengthening cancer prevention in Europe by increasing awareness of the needs, the associated required resources and reducing inequalities in access to cancer prevention across Europe. This article showcases the need for strengthening cancer prevention and introduces the objectives of Cancer Prevention Europe and its foreseen future role in reducing the European cancer burden.

Keywords